SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

  • This share is currently suspended. It was suspended at a price of 0.125
  • There is currently no data for CRV

Directorate Change

22 Apr 2009 10:30

RNS Number : 9721Q
Medsea Estates Group PLC
22 April 2009
 



22 April 2009

Medsea Estates Group Plc

('the Company' or 'Medsea')

Resignation of the Independent Director

Background

On 7 April 2009 the Company posted a circular ("Circular") to convene an Extraordinary General Meeting ("EGM") to be held at 32 Percy Street, London W1T 2DE on 30 April 2009 at 10.30am

The Circular detailed the intention of the Company to enter into a related party transaction in order to complete the disposal ("Disposal") of Medsea UK Limited, a material operating subsidiary, to the current executive directors of the Company.

The Disposal will constitute a fundamental change of business as defined by the AIM Rules. Furthermore, as the Disposal is to the current executive directors of the Company, it would be recognised as a related party transaction under the AIM Rules. Moreover, related party transactions require that an independent director of the Company provide to all shareholders a "fair and reasonable" opinion with regard to the terms of the transactions. The Circular posted on 7 April 2009 included a letter from Neil Craven, the independent director of the Company, confirming that the terms of the Disposal were "fair and reasonable" insofar as its shareholders are concerned.

Resignation of Independent Director

On 7 April 2009, the executive directors became aware that Neil Craven wished to withdraw his "fair and reasonable" opinion provided in the Circular. However, the Circular had been released for posting on the morning of 7 April 2009 which led to a failure to withdraw the Circular in advance of its posting. Furthermore, on 8 April 2009, Neil Craven tendered his resignation from the Company with immediate effect. 

Implications of the Resignation and to the Circular

The Company is currently unable to satisfy the AIM Rule with regard to the provision of a "fair and reasonable" opinion from an independent director for the completion of the Disposal to the related parties being the current executive directors.

Therefore, the board of the Company will seek to appoint a new independent director to review the terms of the Disposal and where appropriate provide a "fair and reasonable" opinion

Finally, the Company intends to issue an addendum to the Circular posted on 7 April 2009.

An announcement will follow in due course to update shareholders of any new information and details of the posting of an addendum to the Circular.

Medsea Estates Group plc 

Tony Gatehouse, Chairman 

Tel: +34 96 570 40 02

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPUUBPCUPBUBP
Date   Source Headline
24th Jul 20257:00 amRNSCancellation - Craven House Capital PLC
23rd Jun 202510:30 amRNSWithdrawl of 'Stmt re Share Price Movement' RNS
23rd Jun 202510:05 amRNSStatement re Share Price Movement
23rd Jun 20257:30 amRNSSuspension - Craven House Capital Plc
23rd Jun 20257:00 amRNSResignation of Nominated Adviser
27th Feb 20257:00 amRNSInterim Results
7th Feb 20254:22 pmRNSTR-1: Notification of major holdings
16th Dec 20242:42 pmRNSResult of AGM
15th Nov 20247:00 amRNSAnnual Results For Year Ended 31 May 2024
10th Sep 20247:00 amRNSInvestee company update: RoseMonkey Ltd
27th Aug 20247:00 amRNSTR-1: Notification of major holdings
23rd Aug 20242:19 pmRNSTR-1: notification of major holdings
5th Jun 20247:00 amRNSInvestee Companies' Update: Bio Vitos
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.